Approximately 50% of U.S. adults have cardiovascular disease (CVD) 1, including coronary artery disease, dyslipidemia, peripheral artery disease, stroke, heart failure, arrhythmia, and inherited cholesterol disorders like familial hypercholesterolemia. Labcorp delivers a comprehensive diagnostic portfolio and complementary analytical tools to help providers identify patients at risk for cardiovascular and metabolic disease and manage and coordinate post-diagnostic management and treatment plans.
Labcorp’s complementary digital platforms help providers stratify risk and guide patient care:
Integrate EHR and Labcorp results into a single patient record for clearer decision-making.
Apply evidence-based guidance individualized to each patient’s cardiovascular results.
Use lab-based dashboards to identify high-risk patients, comorbidities and gaps in care.
CVD rarely occurs in isolation. Patients with diabetes, obesity, chronic kidney disease (CKD), or liver disease face increased cardiovascular risk. For example:
Labcorp supports providers with a multi-therapeutic testing portfolio, guideline-aligned analytics, and digital tools to address the overlapping risks of cardio-kidney-metabolic (CKM) disease
Guidelines6 recommend cholesterol screening every few years for average-risk adults and
more often for high-risk patients.
Reflecting increased awareness of the interrelated nature of cardiometabolic conditions, the latest guidelines from leading medical organizations—including the US Preventive Services Task Force (USPSTF), American Heart Association and American Diabetes Association—have evolved to recommend screening for comorbid cardiometabolic conditions.
Labcorp’s cardiovascular test menu provides clinically relevant insights for conditions affecting the heart muscle, heart valves, and vascular system:
Reach out to your Labcorp representative to learn more about how we can help support diagnostic testing for cardiovascular disease.
Cardiovascular disease is the leading cause of death in the U.S. Risk factors include:
Talk to your provider about guideline-driven cardiovascular screening
Get tested at one of Labcorp’s 2200 patient service centers nationwide
Manage your results with Labcorp Patient™, your secure hub for lab history, appointments, and bills
Labcorp’s portfolio supports diagnosis and management of coronary heart disease, coronary artery disease, heart failure, arrhythmias, dyslipidemia, chest pain evaluation, and inherited cholesterol disorders like familial hypercholesterolemia, as well as related cardiometabolic conditions such as diabetes, obesity, and CKD.
Our menu reflects recommendations from the U.S. Preventive Services Task Force (USPSTF), American Heart Association (AHA), American College of Cardiology (ACC) and American Diabetes Association (ADA), including lipid screening for average- and high-risk adults and comorbidity assessments for patients with diabetes.
By integrating testing across cardiovascular, kidney, metabolic, and liver conditions, providers can detect overlapping risks earlier and tailor interventions to improve outcomes.
Diagnostic Assistant, Clinical Decision Support, and Insight Analytics improve efficiency, support evidence-based care, and help identify at-risk populations.
Reach out to a Labcorp representative to discuss solutions that fit your practice and patients.
